medigraphic.com
ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México

2011, Number 1

<< Back Next >>

Arch Med Urg Mex 2011; 3 (1)

Main microorganisms causing dialysis-associated peritonitis in patients with chronic renal failure in the Emergency Department

Bucio RJ, Gil CT

Language: Spanish
References: 25
Page: 18-23
PDF size: 275.64 Kb.


ABSTRACT

Background: In our country, chronic renal failure represents a public health problem. Continuous ambulatory peritoneal dialysis treatment is symptomatic and replacement of end-stage renal disease. Peritonitis is the main complication, increases morbidity and is the main cause why the change of treatment mode. For cytological diagnosis should be made dialysis fluid but the more specific method to determine the pathogen is the cultivation of which, together with the antibiogram serves as a basis for developing management guidelines and initiate or modify specific antibiotic treatment. Methods: We reviewed the medical records of patients admitted to the Emergency Department with a diagnosis of peritonitis associated with peritoneal dialysis hospitalized during the period of March 1, 2005, to February 29, 2008. Results: Of the 43 patients who met the inclusion criteria, the prevailing age of 50-59 years (28%), being the main pathogenic coagulase-negative Staphylococcus (67%). Conclusions: As reported in other studies, this study found that the main microorganisms causing dialysis-associated peritonitis are grampositive.


REFERENCES

  1. Cruz C, Montenegro J, Olivares MJ. Diálisis peritoneal, insuficiencia renal crónica, México, Trillas 2000; 12: 12-20.

  2. www.encolombia.compediatria34499guiamanejohym-16.

  3. Daugirdas JT. Manual de diálisis, México, MASSON, 2002; 13: 231-40.

  4. Daugirdas JT. Manual de diálisis, México, MASSON, 2002; 34: 533-34.

  5. Korevaar J, Van Vanen JG, Boeschotem EV, Dekker FW, Krediet RT. Evaluation of guidelines for peritoneal dialysis patients: A review from the Netherlands Cooperative Study on the adequacy of Dialysis (NECOSAS). Contrib Nephrol 2003; 140: 142-50.

  6. Cruz C, Montenegro J, Olivares MJ. Diálisis peritoneal, insuficiencia renal crónica, México, Trillas 2000; 12: 22-30.

  7. Alexander SR, Linblad AS, Nolph KD, Novak W, Pediatric CAPD/CCPD in United States In Peritoneal Dialysis. Contemporary Issues in Nephrology 1990; 23: 231-55.

  8. www.aeped.es/protocolos/nefro/9-fracaso-renal-terminal-diálisis.pdf.

  9. Majorca R, Vonesh EF, Cavalli PL. A multi-center, selections adjusted comparison of patient and technique survivals of CAPD and hemodialysis. Perit Dial Int 1991; 11: 118-27.

  10. www.senefroorg/nac/pdf/dialisis12pdf

  11. Fried L, Abidi S, Bernardini J, Johnston JR, Priano B. Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 927-33.

  12. Johnson CC, Baldessarre J, Levison ME. Peritonitis: updater on pathophysiology, clinical manifestations and management. Clin Infect Dis 1997; 24: 1035-47.

  13. Daugirdas JT. Manual de diálisis, México, MASSON, 2002; 19: 323-324.

  14. Berger-Bache B. Resistance mechanisms of grampositive bacteria. Int J Microbiol 2002; 292 (1): 27-35.

  15. Fried L, Bernardini J, Johnston JR, Priano B. Peritonitis indices mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176-82.

  16. Laroche M, Harding G. Primary and secondary peritonitis: an update. Eur J Clin Microbiol Infect Dis 1998; 17: 542-50.

  17. Burkart J, Screiber Mas, Tabor T, Korbet S, Stallard R. Prospective, Multicenter evaluation of patient transfer from peritoneal dialysis to hemodialysis in 1995. Perit Dial Int 1996; 16: S66-S77.

  18. Wilcox CM, Dismukes WE. Spontaneous bacterial peritonitis: a review of pathogenesis. Diagnosis and treatment. Medicine 1987; 66: 447-56.

  19. Daugirdas JT. Manual de diálisis, México, MASSON, 2002; 19: 225-29.

  20. www.hpcorgar/pdf/cronicas2.pdf

  21. Ranyel FS. 1er consenso nacional sobre uso de antibióticos en peritonitis secundaria asociada a diálisis peritoneal continua ambulatoria (DPCA). Enfermedades Infecciosas y Microbiología 2005; 25 (3): 1-3.

  22. Wonh KM, Chan YH, Cheung CY. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis. Am J Kidney Dis 2001; 28 (1): 127-31.

  23. Tao LI PK, IpM, Lew MC. Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis. Peritoneal Dialysis Int 2002; 20: 232-41.

  24. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Amit G y cols. Recomendaciones para las infecciones relacionadas con diálisis peritoneal de la ISPD. Peritoneal Dialysis Int 2005; 25: 107-10.

  25. 25.Ranyel FS. 1er consenso nacional sobre uso de antibióticos en peritonitis secundaria asociada a diálisis peritoneal continua ambulatoria (DPCA). Enfermedades Infecciosas y Microbiología 2005; 25 (3): 7-9.




2020     |     www.medigraphic.com